البورد العراقي للصيدلة السريرية - ✓Anticoagulants for Atrial Fibrillation Dabigatran; Rivaroxaban; Apixaban; Edoxaban ✓Classification Anticoagulant 💊 Dabigatran (Pradaxa): direct thrombin inhibitor 💊Rivaroxaban (Xarelto): direct factor Xa inhibitor ...
![Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fc8073074af9c50576c23cf71f14d56e2ae1ba82/6-Figure3-1.png)
Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. | Semantic Scholar
![Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - ScienceDirect Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1052305719306834-gr1.jpg)
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan - ScienceDirect
![Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717370067-gr5.jpg)
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect
![Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants | Journal of the American College of Cardiology Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/318ce34f-9d46-40b0-a6b1-4db9d39915c9/fx1.jpg)
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants | Journal of the American College of Cardiology
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS | PLOS ONE
![Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation | Journal of the American College of Cardiology Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/4a261a66-43fe-4c91-8816-e0f3b72db49e/fx1.jpg)
Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation | Journal of the American College of Cardiology
![JCM | Free Full-Text | Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO) JCM | Free Full-Text | Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)](https://www.mdpi.com/jcm/jcm-10-04185/article_deploy/html/images/jcm-10-04185-g001.png)
JCM | Free Full-Text | Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
![Cureus | Appropriateness of Prescribing Rivaroxaban at King Khalid University Hospital Riyadh | Article Cureus | Appropriateness of Prescribing Rivaroxaban at King Khalid University Hospital Riyadh | Article](https://assets.cureus.com/uploads/figure/file/302640/lightbox_f2e0ac50625711ec81abe73165a6ffcf-55.png)